![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 4
Zeitschriftenartikel
Imterat, Majdi 
ORCID: https://orcid.org/0000-0001-7174-8591; Bizzarri, Nicolò ORCID: https://orcid.org/0000-0002-1727-904X; Fruscio, Robert ORCID: https://orcid.org/0000-0001-5688-2194; Perrone, Anna Myriam; Traut, Alexander; Du Bois, Andreas ORCID: https://orcid.org/0000-0002-8477-506X; Rosati, Andrea ORCID: https://orcid.org/0000-0003-3126-9400; Ferrari, Debora; De Iaco, Pierandrea ORCID: https://orcid.org/0000-0002-8841-6531; Ataseven, Beyhan; Ergasti, Raffaella ORCID: https://orcid.org/0000-0002-5066-1419; Volontè, Silvia; Tesei, Marco; Heitz, Florian; Perri, Maria Teresa; Concin, Nicole ORCID: https://orcid.org/0000-0002-9795-2643; Fanfani, Francesco ORCID: https://orcid.org/0000-0003-1991-7284; Scambia, Giovanni ORCID: https://orcid.org/0000-0003-2758-1063; Fagotti, Anna ORCID: https://orcid.org/0000-0001-5579-335X und Harter, Philipp
(2022):
Impact of substage and histologic type in stage I ovarian carcinoma survival: a multicenter retrospective observational study.
In: International Journal of Gynecologic Cancer, Bd. 33, Nr. 1: S. 42-49
ORCID: https://orcid.org/0000-0001-7174-8591; Bizzarri, Nicolò ORCID: https://orcid.org/0000-0002-1727-904X; Fruscio, Robert ORCID: https://orcid.org/0000-0001-5688-2194; Perrone, Anna Myriam; Traut, Alexander; Du Bois, Andreas ORCID: https://orcid.org/0000-0002-8477-506X; Rosati, Andrea ORCID: https://orcid.org/0000-0003-3126-9400; Ferrari, Debora; De Iaco, Pierandrea ORCID: https://orcid.org/0000-0002-8841-6531; Ataseven, Beyhan; Ergasti, Raffaella ORCID: https://orcid.org/0000-0002-5066-1419; Volontè, Silvia; Tesei, Marco; Heitz, Florian; Perri, Maria Teresa; Concin, Nicole ORCID: https://orcid.org/0000-0002-9795-2643; Fanfani, Francesco ORCID: https://orcid.org/0000-0003-1991-7284; Scambia, Giovanni ORCID: https://orcid.org/0000-0003-2758-1063; Fagotti, Anna ORCID: https://orcid.org/0000-0001-5579-335X und Harter, Philipp
(2022):
Impact of substage and histologic type in stage I ovarian carcinoma survival: a multicenter retrospective observational study.
In: International Journal of Gynecologic Cancer, Bd. 33, Nr. 1: S. 42-49
Schouten, Philip C.; Richters, Lisa; Vis, Daniel J.; Kommoss, Stefan; Dijk, Ewald van; Ernst, Corinna; Kluin, Roelof J. C.; Marme, Frederik; Lips, Esther H.; Schmidt, Sandra; Scheerman, Esther; Prieske, Katharina; Deurzen, Carolien H. M. van; Burges, Alexander; Ewing-Graham, Patricia C.; Dietrich, Dimo; Jager, Agnes; De Gregorio, Nikolaus; Hauke, Jan; Du Bois, Andreas; Nederlof, Petra M.; Wessels, Lodewyk F.; Hahnen, Eric; Harter, Philipp; Linn, Sabine C. und Schmutzler, Rita K.
(2021):
Ovarian Cancer-Specific BRCA-like Copy-Number Aberration Classifiers Detect Mutations Associated with Homologous Recombination Deficiency in the AGO-TR1 Trial.
In: Clinical Cancer Research, Bd. 27, Nr. 23: S. 6559-6569
Colomban, Olivier; Tod, Michel; Leary, Alexandra; Ray-Coquard, Isabelle; Lortholary, Alain; Hardy-Bessard, Anne Claire; Pfisterer, Jacobus; Du Bois, Andreas; Kurzeder, Christian; Burges, Alexander; Peron, Julien; Freyer, Gilles und You, Benoit
(2019):
Early Modeled Longitudinal CA-125 Kinetics and Survival of Ovarian Cancer Patients: A GINECO AGO MRC CTU Study.
In: Clinical Cancer Research, Bd. 25, Nr. 17: S. 5342-5350
Du Bois, Andreas; Ewald-Riegler, Nina; De Gregorio, Nikolaus; Reuss, Alexander; Mahner, Sven; Fotopoulou, Christina; Kommoss, Friedrich; Schmalfeldt, Barbara; Hilpert, Felix; Fehm, Tanja; Burges, Alexander; Meier, Werner; Hillemanns, Peter; Hanker, Lars; Hasenburg, Annette; Strauss, Hans-Georg; Hellriegel, Martin; Wimberger, Pauline; Keyver-Paik, Mignon-Denise; Baumann, Klaus; Canzler, Ulrich; Wollschlaeger, Kerstin; Forner, Dirk; Pfisterer, Jacobus; Schröder, Willibald; Münstedt, Karsten; Richter, Barbara; Kommoss, Stefan und Hauptmann, Steffen
(2016):
Corrigendum to "Borderline tumours of the ovary: A cohort study of the Arbeitsgemeinschaft Gynakologische Onkologie AGO Study Group" (Eur J Cancer vol 49, pg 1905, 2013).
In: European Journal of Cancer, Bd. 65: S. 192-193